Praj Industries Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/4yufq8bsja8hkvix8ougdqdg.pdf

Key Takeaways


Bioenergy: The Feedstock Shift Is Complete

Joshipura: "However, the indicative grain price is very high, posing a big challenge on project viability."

Praj GenX & Engineering: Capitalized, Approved, Waiting


Services: The Silent Growth Engine


New Molecules & New Markets

Joshipura: "The idea of a co-product is that it does not compromise what's already existing, but it only allows you to extract more from the other streams that come out of the project."

CBG & 2G: Gradual Progress, One Breakthrough

Joshipura: "if we can think of a plant located in the middle of a Napier grass plantation, then that is a very good one to have, because then all the nutrients that come back from the process in terms of liquid and solid bio-fertilizers can all go back to the same field, so it becomes very, very, I mean, a completely closed loop, so no water required, no, the water that comes goes back."

Margins & Below-the-Line

Raole: "It is mainly the mark-to-market of the forward contracts, and it is not the cash losses which we have booked."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue doublingManagement stands by the statement of doubling revenue in 3 years from today3 years from Q2 FY25
GenX revenue rampRevenue from Mangalore facility to start kicking in meaningfullyQ4 FY25, definitely next year
Engineering order bookingOrder booking to build up meaningfully from current ₹200-250 cr/quarter run-rateH2 FY25 onwards
Export order inflowExpected back to normal after large contracts missed closing in Q2End of nine months (Q3 FY25)
CBG invoicingNoticeable sales and invoicing from five plants currently under executionH2 FY25
IOCL 2G plant commissioningCellulosic ethanol plant recommissioning progressing as per planH2 FY25
Gross marginRange expected to be more or less same as Q2's 47%Sustainable basis
SAF disclosureCompany will start talking about SAFH2 FY25

Key Metrics

MetricQ2 FY25
Consolidated income from operations₹816 cr, vs ₹882 cr in Q2 FY24
PBT₹74.4 cr, vs ₹84.8 cr in Q2 FY24
PAT₹53.8 cr, vs ₹62.3 cr in Q2 FY24
H1 FY25 income from operations₹1,515 cr, vs ₹1,619 cr in H1 FY24
H1 FY25 PBT before exceptional items₹153 cr, vs ₹162 cr in H1 FY24
H1 FY25 PAT₹138 cr, vs ₹121 cr in H1 FY24
Export revenue share27% of Q2 FY25 revenue
Revenue mix68% bioenergy, 24% engineering, 8% PHS
Order intake₹921 cr, 94% domestic; 88% bioenergy, 6% engineering, 6% PHS
Order backlog₹4,150 cr as of Sep '24, 72% domestic
Cash in hand₹751 cr as of 30th Sep '24
MTM loss on forward contracts₹10 cr in Q2 FY25
Services business order book40% higher in H1 FY25 than full FY24 order book for the segment
Domestic bioenergy order book share from starchy feedstock100% in Q2 FY25
Gross margin47%, vs 50% in Q1 FY25